Last edition
News about Global Pharma
Abzena Welcomes Taylor Boyd as New CBO
Boyd has a strong track record of success within the life sciences and CDMO industry, primarily in strategic transactions and capital-raising activities.
Global Pharma | 27/02/2025 | By Aishwarya | 756
MediBeacon Transdermal GFR System Receives Device Approval in China
MediBeacon Inc. announced the National Medical Products Administration (NMPA) in China has approved the MediBeacon® TGFR Monitor and TGFR Sensor for the assessment of kidney function in patients with normal or impaired renal function.
Global Pharma | 26/02/2025 | By Manvi | 1109
Nimbus Therapeutics Hits Preclinical Research Milestone with Lilly
Throughout their collaboration, Nimbus has leveraged its computational approaches and structure-based drug design capabilities to help overcome these historical obstacles.
Global Pharma | 26/02/2025 | By Aishwarya | 429
Averto Medical's ColoSeal ICD System Earns FDA Breakthrough Device Designation
Averto Medical, a clinical-stage medical device company pioneering minimally invasive gastrointestinal care, announce that the US Food and Drug Administration (FDA) has granted Breakthrough Device Designation for its ColoSeal™ Intraluminal Colonic Diversion (ICD) System.
Global Pharma | 26/02/2025 | By Manvi | 675
PharmSight to Expand Globally with New Strategic Hub Launch in Boston
PharmSight plans to broaden its global footprint by opening new offices in Europe and the Middle East and launching an innovation center dedicated to AI-driven solutions.
Global Pharma | 26/02/2025 | By Aishwarya | 579
Thermo Fisher Scientific Plans to Acquire Solventum Purification and Filtration Business
Solventum’s Purification & Filtration business is a provider of purification and filtration technologies used in the production of biologics as well as in medical technologies and industrial applications.
Global Pharma | 26/02/2025 | By Aishwarya | 548
Under the terms of the expanded MOU, WuXi XDC's fully integrated ADC discovery service platform will significantly boost the speed and efficiency of LigaChem's ADC development programs.
Global Pharma | 25/02/2025 | By Manvi | 239
Summit Therapeutics and Pfizer to Explore Ivonescimab in Combination with Pfizer's ADCs
Akeso Inc.'s partner, Summit Therapeutics, has entered a clinical trial collaboration with Pfizer to evaluate ivonescimab, a PD-1/VEGF bispecific antibody, in combination with Pfizer’s ADCs for multiple solid tumour treatments.
Global Pharma | 25/02/2025 | By Manvi | 310
GSK Completes Acquisition of IDRx
IDRX-42 has demonstrated activity against all clinically relevant primary and secondary KIT mutations, a key medical need in current GIST treatment.
Global Pharma | 25/02/2025 | By Aishwarya | 354
Pfizer Signs Marketing and Supply Deal with Mylan Pharmaceuticals
Under the terms of the agreement, Pfizer will retain ownership of the brands, while Mylan will be responsible for their marketing and sales within India for a period of five years.
Global Pharma | 25/02/2025 | By Aishwarya | 833
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy